nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0557	0.126	CbGbCtD
Brinzolamide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0523	0.119	CbGbCtD
Brinzolamide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0523	0.119	CbGbCtD
Brinzolamide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0473	0.107	CbGbCtD
Brinzolamide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0473	0.107	CbGbCtD
Brinzolamide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0409	0.0925	CbGbCtD
Brinzolamide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0397	0.0898	CbGbCtD
Brinzolamide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0359	0.0812	CbGbCtD
Brinzolamide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0359	0.0812	CbGbCtD
Brinzolamide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0344	0.0779	CbGbCtD
Brinzolamide—CA6—saliva—acquired immunodeficiency syndrome	0.0211	0.175	CbGeAlD
Brinzolamide—CA1—nerve—acquired immunodeficiency syndrome	0.00644	0.0536	CbGeAlD
Brinzolamide—CA4—nerve—acquired immunodeficiency syndrome	0.00503	0.0419	CbGeAlD
Brinzolamide—CA1—blood plasma—acquired immunodeficiency syndrome	0.00487	0.0405	CbGeAlD
Brinzolamide—CA7—digestive system—acquired immunodeficiency syndrome	0.00364	0.0303	CbGeAlD
Brinzolamide—CA9—digestive system—acquired immunodeficiency syndrome	0.0032	0.0266	CbGeAlD
Brinzolamide—CA2—blood plasma—acquired immunodeficiency syndrome	0.00316	0.0262	CbGeAlD
Brinzolamide—CA14—spinal cord—acquired immunodeficiency syndrome	0.00278	0.0231	CbGeAlD
Brinzolamide—CA12—digestive system—acquired immunodeficiency syndrome	0.00236	0.0197	CbGeAlD
Brinzolamide—CA7—brain—acquired immunodeficiency syndrome	0.00215	0.0179	CbGeAlD
Brinzolamide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00204	0.0169	CbGeAlD
Brinzolamide—CA5B—blood—acquired immunodeficiency syndrome	0.00202	0.0168	CbGeAlD
Brinzolamide—CA12—lung—acquired immunodeficiency syndrome	0.00197	0.0164	CbGeAlD
Brinzolamide—CA1—lymphoid tissue—acquired immunodeficiency syndrome	0.0019	0.0158	CbGeAlD
Brinzolamide—CA1—digestive system—acquired immunodeficiency syndrome	0.00187	0.0156	CbGeAlD
Brinzolamide—CA5B—vagina—acquired immunodeficiency syndrome	0.00187	0.0156	CbGeAlD
Brinzolamide—CA12—nervous system—acquired immunodeficiency syndrome	0.00183	0.0152	CbGeAlD
Brinzolamide—CA14—brain—acquired immunodeficiency syndrome	0.00179	0.0149	CbGeAlD
Brinzolamide—CA1—blood—acquired immunodeficiency syndrome	0.00178	0.0148	CbGeAlD
Brinzolamide—CA5B—lung—acquired immunodeficiency syndrome	0.00177	0.0147	CbGeAlD
Brinzolamide—CA12—central nervous system—acquired immunodeficiency syndrome	0.00176	0.0146	CbGeAlD
Brinzolamide—CA2—retina—acquired immunodeficiency syndrome	0.00173	0.0144	CbGeAlD
Brinzolamide—CA1—bone marrow—acquired immunodeficiency syndrome	0.00173	0.0144	CbGeAlD
Brinzolamide—CA1—spinal cord—acquired immunodeficiency syndrome	0.00172	0.0143	CbGeAlD
Brinzolamide—CA5B—nervous system—acquired immunodeficiency syndrome	0.00164	0.0136	CbGeAlD
Brinzolamide—CA5B—central nervous system—acquired immunodeficiency syndrome	0.00158	0.0131	CbGeAlD
Brinzolamide—CA1—lung—acquired immunodeficiency syndrome	0.00156	0.013	CbGeAlD
Brinzolamide—CA2—skin of body—acquired immunodeficiency syndrome	0.00152	0.0126	CbGeAlD
Brinzolamide—CA4—digestive system—acquired immunodeficiency syndrome	0.00146	0.0122	CbGeAlD
Brinzolamide—CA1—nervous system—acquired immunodeficiency syndrome	0.00145	0.012	CbGeAlD
Brinzolamide—CA12—brain—acquired immunodeficiency syndrome	0.0014	0.0116	CbGeAlD
Brinzolamide—CA4—blood—acquired immunodeficiency syndrome	0.00139	0.0116	CbGeAlD
Brinzolamide—CA1—central nervous system—acquired immunodeficiency syndrome	0.00139	0.0116	CbGeAlD
Brinzolamide—CA4—bone marrow—acquired immunodeficiency syndrome	0.00135	0.0112	CbGeAlD
Brinzolamide—CA4—spinal cord—acquired immunodeficiency syndrome	0.00134	0.0112	CbGeAlD
Brinzolamide—CA5B—brain—acquired immunodeficiency syndrome	0.00125	0.0104	CbGeAlD
Brinzolamide—CA2—lymphoid tissue—acquired immunodeficiency syndrome	0.00123	0.0102	CbGeAlD
Brinzolamide—CA4—lung—acquired immunodeficiency syndrome	0.00122	0.0102	CbGeAlD
Brinzolamide—CA2—digestive system—acquired immunodeficiency syndrome	0.00121	0.0101	CbGeAlD
Brinzolamide—CA5B—lymph node—acquired immunodeficiency syndrome	0.00121	0.0101	CbGeAlD
Brinzolamide—CA2—blood—acquired immunodeficiency syndrome	0.00116	0.00962	CbGeAlD
Brinzolamide—CA4—nervous system—acquired immunodeficiency syndrome	0.00113	0.00941	CbGeAlD
Brinzolamide—CA2—bone marrow—acquired immunodeficiency syndrome	0.00112	0.0093	CbGeAlD
Brinzolamide—CA2—spinal cord—acquired immunodeficiency syndrome	0.00111	0.00926	CbGeAlD
Brinzolamide—CA1—brain—acquired immunodeficiency syndrome	0.00111	0.00921	CbGeAlD
Brinzolamide—CA4—central nervous system—acquired immunodeficiency syndrome	0.00109	0.00906	CbGeAlD
Brinzolamide—CA2—vagina—acquired immunodeficiency syndrome	0.00107	0.00891	CbGeAlD
Brinzolamide—CA1—lymph node—acquired immunodeficiency syndrome	0.00107	0.0089	CbGeAlD
Brinzolamide—CA2—lung—acquired immunodeficiency syndrome	0.00101	0.00843	CbGeAlD
Brinzolamide—CA2—nervous system—acquired immunodeficiency syndrome	0.000939	0.00781	CbGeAlD
Brinzolamide—CA2—central nervous system—acquired immunodeficiency syndrome	0.000904	0.00752	CbGeAlD
Brinzolamide—CA4—brain—acquired immunodeficiency syndrome	0.000865	0.0072	CbGeAlD
Brinzolamide—CA4—lymph node—acquired immunodeficiency syndrome	0.000836	0.00695	CbGeAlD
Brinzolamide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000783	0.00651	CbGeAlD
Brinzolamide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000746	0.0062	CbGeAlD
Brinzolamide—CA2—brain—acquired immunodeficiency syndrome	0.000717	0.00597	CbGeAlD
Brinzolamide—CA2—lymph node—acquired immunodeficiency syndrome	0.000693	0.00577	CbGeAlD
Brinzolamide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000606	0.00504	CbGeAlD
Brinzolamide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000583	0.00485	CbGeAlD
Brinzolamide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000435	0.000992	CcSEcCtD
Brinzolamide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000434	0.000991	CcSEcCtD
Brinzolamide—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000434	0.000991	CcSEcCtD
Brinzolamide—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000434	0.00099	CcSEcCtD
Brinzolamide—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000433	0.000987	CcSEcCtD
Brinzolamide—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000433	0.000987	CcSEcCtD
Brinzolamide—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000432	0.000986	CcSEcCtD
Brinzolamide—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000432	0.000986	CcSEcCtD
Brinzolamide—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000432	0.000986	CcSEcCtD
Brinzolamide—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000431	0.000984	CcSEcCtD
Brinzolamide—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000431	0.000984	CcSEcCtD
Brinzolamide—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000431	0.000983	CcSEcCtD
Brinzolamide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00043	0.000983	CcSEcCtD
Brinzolamide—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00043	0.000981	CcSEcCtD
Brinzolamide—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000428	0.000978	CcSEcCtD
Brinzolamide—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000428	0.000977	CcSEcCtD
Brinzolamide—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000428	0.000976	CcSEcCtD
Brinzolamide—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000427	0.000974	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000427	0.000974	CcSEcCtD
Brinzolamide—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000426	0.000972	CcSEcCtD
Brinzolamide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000424	0.000969	CcSEcCtD
Brinzolamide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000424	0.000968	CcSEcCtD
Brinzolamide—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000424	0.000968	CcSEcCtD
Brinzolamide—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000424	0.000968	CcSEcCtD
Brinzolamide—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000424	0.000967	CcSEcCtD
Brinzolamide—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000423	0.000966	CcSEcCtD
Brinzolamide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000421	0.00096	CcSEcCtD
Brinzolamide—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000421	0.00096	CcSEcCtD
Brinzolamide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00042	0.00096	CcSEcCtD
Brinzolamide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00042	0.00096	CcSEcCtD
Brinzolamide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00042	0.000959	CcSEcCtD
Brinzolamide—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000419	0.000955	CcSEcCtD
Brinzolamide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000418	0.000954	CcSEcCtD
Brinzolamide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000417	0.000953	CcSEcCtD
Brinzolamide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000417	0.000952	CcSEcCtD
Brinzolamide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000416	0.00095	CcSEcCtD
Brinzolamide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000416	0.00095	CcSEcCtD
Brinzolamide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000416	0.000949	CcSEcCtD
Brinzolamide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000415	0.000947	CcSEcCtD
Brinzolamide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000415	0.000947	CcSEcCtD
Brinzolamide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000414	0.000945	CcSEcCtD
Brinzolamide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000413	0.000943	CcSEcCtD
Brinzolamide—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000413	0.000942	CcSEcCtD
Brinzolamide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000412	0.000941	CcSEcCtD
Brinzolamide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000411	0.000939	CcSEcCtD
Brinzolamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000411	0.000938	CcSEcCtD
Brinzolamide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000411	0.000937	CcSEcCtD
Brinzolamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00041	0.000936	CcSEcCtD
Brinzolamide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000409	0.000935	CcSEcCtD
Brinzolamide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000409	0.000933	CcSEcCtD
Brinzolamide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000408	0.000932	CcSEcCtD
Brinzolamide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000408	0.000932	CcSEcCtD
Brinzolamide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000408	0.000932	CcSEcCtD
Brinzolamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000407	0.000929	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000406	0.000926	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000404	0.000923	CcSEcCtD
Brinzolamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000404	0.000922	CcSEcCtD
Brinzolamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000404	0.000922	CcSEcCtD
Brinzolamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000403	0.000921	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000403	0.00092	CcSEcCtD
Brinzolamide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000403	0.00092	CcSEcCtD
Brinzolamide—Pain—Indinavir—acquired immunodeficiency syndrome	0.0004	0.000914	CcSEcCtD
Brinzolamide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.0004	0.000913	CcSEcCtD
Brinzolamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.0004	0.000913	CcSEcCtD
Brinzolamide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.000912	CcSEcCtD
Brinzolamide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000399	0.00091	CcSEcCtD
Brinzolamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000398	0.000908	CcSEcCtD
Brinzolamide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000397	0.000907	CcSEcCtD
Brinzolamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000397	0.000907	CcSEcCtD
Brinzolamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000396	0.000905	CcSEcCtD
Brinzolamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000396	0.000905	CcSEcCtD
Brinzolamide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000396	0.000903	CcSEcCtD
Brinzolamide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000396	0.000903	CcSEcCtD
Brinzolamide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000394	0.0009	CcSEcCtD
Brinzolamide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000393	0.000898	CcSEcCtD
Brinzolamide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000393	0.000897	CcSEcCtD
Brinzolamide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000393	0.000897	CcSEcCtD
Brinzolamide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000393	0.000897	CcSEcCtD
Brinzolamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00039	0.000891	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00039	0.000891	CcSEcCtD
Brinzolamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000389	0.000889	CcSEcCtD
Brinzolamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000388	0.000886	CcSEcCtD
Brinzolamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000386	0.000881	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000386	0.00088	CcSEcCtD
Brinzolamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000385	0.000878	CcSEcCtD
Brinzolamide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000384	0.000877	CcSEcCtD
Brinzolamide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000384	0.000877	CcSEcCtD
Brinzolamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000384	0.000877	CcSEcCtD
Brinzolamide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000384	0.000876	CcSEcCtD
Brinzolamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000383	0.000874	CcSEcCtD
Brinzolamide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000383	0.000874	CcSEcCtD
Brinzolamide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000382	0.000872	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000382	0.000872	CcSEcCtD
Brinzolamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000381	0.000871	CcSEcCtD
Brinzolamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000381	0.000871	CcSEcCtD
Brinzolamide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00038	0.000868	CcSEcCtD
Brinzolamide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00038	0.000868	CcSEcCtD
Brinzolamide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000378	0.000864	CcSEcCtD
Brinzolamide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000378	0.000864	CcSEcCtD
Brinzolamide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000378	0.000863	CcSEcCtD
Brinzolamide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000377	0.000861	CcSEcCtD
Brinzolamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000377	0.000861	CcSEcCtD
Brinzolamide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000376	0.000859	CcSEcCtD
Brinzolamide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000376	0.000858	CcSEcCtD
Brinzolamide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000375	0.000856	CcSEcCtD
Brinzolamide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000375	0.000856	CcSEcCtD
Brinzolamide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000375	0.000856	CcSEcCtD
Brinzolamide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000374	0.000854	CcSEcCtD
Brinzolamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000373	0.000851	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000372	0.00085	CcSEcCtD
Brinzolamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000372	0.000849	CcSEcCtD
Brinzolamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00037	0.000846	CcSEcCtD
Brinzolamide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000369	0.000843	CcSEcCtD
Brinzolamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000369	0.000843	CcSEcCtD
Brinzolamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000368	0.000841	CcSEcCtD
Brinzolamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000368	0.00084	CcSEcCtD
Brinzolamide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000367	0.000837	CcSEcCtD
Brinzolamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000366	0.000836	CcSEcCtD
Brinzolamide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000366	0.000836	CcSEcCtD
Brinzolamide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000366	0.000835	CcSEcCtD
Brinzolamide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000366	0.000835	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.000834	CcSEcCtD
Brinzolamide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000365	0.000834	CcSEcCtD
Brinzolamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.000833	CcSEcCtD
Brinzolamide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000365	0.000833	CcSEcCtD
Brinzolamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000365	0.000832	CcSEcCtD
Brinzolamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000364	0.000831	CcSEcCtD
Brinzolamide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000363	0.000828	CcSEcCtD
Brinzolamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000363	0.000828	CcSEcCtD
Brinzolamide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000362	0.000826	CcSEcCtD
Brinzolamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000361	0.000825	CcSEcCtD
Brinzolamide—Rash—Abacavir—acquired immunodeficiency syndrome	0.00036	0.000821	CcSEcCtD
Brinzolamide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000359	0.000821	CcSEcCtD
Brinzolamide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000358	0.000816	CcSEcCtD
Brinzolamide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000357	0.000815	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000357	0.000814	CcSEcCtD
Brinzolamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000356	0.000813	CcSEcCtD
Brinzolamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000356	0.000813	CcSEcCtD
Brinzolamide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000354	0.000808	CcSEcCtD
Brinzolamide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000352	0.000805	CcSEcCtD
Brinzolamide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000352	0.000804	CcSEcCtD
Brinzolamide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.000802	CcSEcCtD
Brinzolamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000351	0.000802	CcSEcCtD
Brinzolamide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000349	0.000797	CcSEcCtD
Brinzolamide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000349	0.000797	CcSEcCtD
Brinzolamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000349	0.000796	CcSEcCtD
Brinzolamide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000348	0.000794	CcSEcCtD
Brinzolamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000345	0.000788	CcSEcCtD
Brinzolamide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000345	0.000787	CcSEcCtD
Brinzolamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000345	0.000787	CcSEcCtD
Brinzolamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000344	0.000786	CcSEcCtD
Brinzolamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000344	0.000785	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000343	0.000784	CcSEcCtD
Brinzolamide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.000778	CcSEcCtD
Brinzolamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.000777	CcSEcCtD
Brinzolamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000339	0.000774	CcSEcCtD
Brinzolamide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000338	0.000772	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000338	0.000771	CcSEcCtD
Brinzolamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000337	0.00077	CcSEcCtD
Brinzolamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000336	0.000768	CcSEcCtD
Brinzolamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000336	0.000767	CcSEcCtD
Brinzolamide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000336	0.000767	CcSEcCtD
Brinzolamide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000336	0.000767	CcSEcCtD
Brinzolamide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000335	0.000765	CcSEcCtD
Brinzolamide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000335	0.000764	CcSEcCtD
Brinzolamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000333	0.00076	CcSEcCtD
Brinzolamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.000757	CcSEcCtD
Brinzolamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000331	0.000756	CcSEcCtD
Brinzolamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000328	0.000748	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000327	0.000747	CcSEcCtD
Brinzolamide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000326	0.000744	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.000742	CcSEcCtD
Brinzolamide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000325	0.000742	CcSEcCtD
Brinzolamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.000741	CcSEcCtD
Brinzolamide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000323	0.000737	CcSEcCtD
Brinzolamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000323	0.000736	CcSEcCtD
Brinzolamide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000322	0.000735	CcSEcCtD
Brinzolamide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00032	0.000731	CcSEcCtD
Brinzolamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00032	0.000731	CcSEcCtD
Brinzolamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00032	0.000731	CcSEcCtD
Brinzolamide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00032	0.000729	CcSEcCtD
Brinzolamide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000317	0.000725	CcSEcCtD
Brinzolamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.000725	CcSEcCtD
Brinzolamide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000317	0.000724	CcSEcCtD
Brinzolamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000316	0.000722	CcSEcCtD
Brinzolamide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000315	0.00072	CcSEcCtD
Brinzolamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000313	0.000714	CcSEcCtD
Brinzolamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.000713	CcSEcCtD
Brinzolamide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.000712	CcSEcCtD
Brinzolamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000311	0.00071	CcSEcCtD
Brinzolamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.000709	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.000708	CcSEcCtD
Brinzolamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.000707	CcSEcCtD
Brinzolamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00031	0.000707	CcSEcCtD
Brinzolamide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000307	0.000702	CcSEcCtD
Brinzolamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.000693	CcSEcCtD
Brinzolamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000303	0.000691	CcSEcCtD
Brinzolamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000299	0.000684	CcSEcCtD
Brinzolamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000299	0.000683	CcSEcCtD
Brinzolamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000299	0.000683	CcSEcCtD
Brinzolamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000298	0.00068	CcSEcCtD
Brinzolamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.000676	CcSEcCtD
Brinzolamide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000295	0.000674	CcSEcCtD
Brinzolamide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000295	0.000673	CcSEcCtD
Brinzolamide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000293	0.00067	CcSEcCtD
Brinzolamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000293	0.000668	CcSEcCtD
Brinzolamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00029	0.000661	CcSEcCtD
Brinzolamide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000288	0.000658	CcSEcCtD
Brinzolamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.000652	CcSEcCtD
Brinzolamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000281	0.000642	CcSEcCtD
Brinzolamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.000641	CcSEcCtD
Brinzolamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.000639	CcSEcCtD
Brinzolamide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000279	0.000637	CcSEcCtD
Brinzolamide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000279	0.000636	CcSEcCtD
Brinzolamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000278	0.000635	CcSEcCtD
Brinzolamide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.000634	CcSEcCtD
Brinzolamide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000277	0.000633	CcSEcCtD
Brinzolamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000277	0.000632	CcSEcCtD
Brinzolamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.000617	CcSEcCtD
Brinzolamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000269	0.000614	CcSEcCtD
Brinzolamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.000611	CcSEcCtD
Brinzolamide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.000609	CcSEcCtD
Brinzolamide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.000609	CcSEcCtD
Brinzolamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.000608	CcSEcCtD
Brinzolamide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.000605	CcSEcCtD
Brinzolamide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.000604	CcSEcCtD
Brinzolamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.0006	CcSEcCtD
Brinzolamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.000591	CcSEcCtD
Brinzolamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.000589	CcSEcCtD
Brinzolamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.000588	CcSEcCtD
Brinzolamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000254	0.00058	CcSEcCtD
Brinzolamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.000574	CcSEcCtD
Brinzolamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.000569	CcSEcCtD
Brinzolamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.000568	CcSEcCtD
Brinzolamide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.000563	CcSEcCtD
Brinzolamide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.000563	CcSEcCtD
Brinzolamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.000561	CcSEcCtD
Brinzolamide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00056	CcSEcCtD
Brinzolamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000547	CcSEcCtD
Brinzolamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.000543	CcSEcCtD
Brinzolamide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.000542	CcSEcCtD
Brinzolamide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.000542	CcSEcCtD
Brinzolamide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.000539	CcSEcCtD
Brinzolamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000531	CcSEcCtD
Brinzolamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000522	CcSEcCtD
Brinzolamide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.000517	CcSEcCtD
Brinzolamide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.000517	CcSEcCtD
Brinzolamide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.000514	CcSEcCtD
Brinzolamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000511	CcSEcCtD
Brinzolamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000487	CcSEcCtD
